The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
MS201944-0170: A phase IIa study to investigate the clinical activity and safety of avelumab in combination with cetuximab plus gemcitabine and cisplatin in patients with advanced squamous NSCLC.
 
Fortunato Ciardiello
Consulting or Advisory Role - Amgen; Bayer; Merck KGaA; Pfizer; Roche/Genentech
Research Funding - Amgen (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Ipsen (Inst); Merck KGaA (Inst); Merck Sharp & Dohme (Inst); Roche/Genentech (Inst); SERVIER (Inst); Symphogen (Inst)
 
Manuel Cobo Dols
No Relationships to Disclose
 
Oscar Juan Vidal
Consulting or Advisory Role - Abbvie; AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Pfizer; Roche/Genentech
Research Funding - AstraZeneca Spain (Inst); Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Merck Sharp & Dohme; Roche/Genentech
 
Luis G. Paz-Ares
Leadership - European Medicines Agency (I); Genomica
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Incyte; Lilly; Merck Serono; MSD; Novartis; Pfizer; PharmaMar; Roche/Genentech; Sysmex
Travel, Accommodations, Expenses - AstraZeneca; AstraZeneca Spain; Bristol-Myers Squibb; Bristol-Myers Squibb; Lilly; MSD; Pfizer; Roche
Other Relationship - Amgen (I); Ipsen (I); Merck (I); Novartis (I); Pfizer (I); Roche; Roche (I); Sanofi (I); SERVIER (I)
 
Javier de Castro Carpeño
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dome; Pfizer; Roche
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dome; Roche
 
Enriqueta Felip
Consulting or Advisory Role - Abbvie; AstraZeneca; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Guardant Health; Janssen; Lilly; Merck KGaA; Merck Sharp & Dome; Novartis; Pfizer; Roche; Takeda
Speakers' Bureau - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck KGaA; Merck Sharp & Dome; Novartis; Pfizer; Roche; Takeda
Research Funding - EMD Serono (Inst); Merck (Inst)
 
Rosario Garcia Campelo
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD Oncology; Novartis; Pfizer; Roche/Genentech; Takeda
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD Oncology; Novartis; Pfizer; Roche; Takeda
 
Gyorgy Losonczy
No Relationships to Disclose
 
Zsuzsanna Szalai
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline
 
David Vicente
Consulting or Advisory Role - AstraZeneca; MSD; Pfizer; Roche
Speakers' Bureau - Boehringer Ingelheim; Bristol-Myers Squibb
Travel, Accommodations, Expenses - AstraZeneca
 
Andreas Schröder
Employment - Merck KGaA
Leadership - Merck KGaA
Stock and Other Ownership Interests - Merck KGaA
Patents, Royalties, Other Intellectual Property - Merck KGaA
 
Frank Beier
Employment - Merck KGaA
Stock and Other Ownership Interests - Merck KGaA
Travel, Accommodations, Expenses - Merck KGaA
 
Prasad Bhandge
Employment - Merck KGaA (I)
Consulting or Advisory Role - Merck KGaA
 
Gabriella Galffy
Consulting or Advisory Role - AstraZeneca; Berlin-Chemie; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Novartis; Roche
Speakers' Bureau - AstraZeneca; Berlin-Chemie; Boehringer Ingelheim; Bristol-Myers Squibb; Ipsen; MSD; Mylan; Novartis; Pfizer; Roche